STM2120

• CAT Number: I041134
• CAS Number: 2762286-04-2
• Molecular Formula: C18H15N5O2
• Molecular Weight: 333.34
• Purity: ≥95%
• Synonyms: N-[(5-methylimidazo[1,2-a]pyridin-2-yl)methyl]-4-oxopyrido[1,2-a]pyrimidine-2-carboxamide
• InChI: InChI=1S/C18H15N5O2/c1-12-5-4-7-15-20-13(11-23(12)15)10-19-18(25)14-9-17(24)22-8-3-2-6-16(22)21-14/h2-9,11H,10H2,1H3,(H,19,25)
• InChIKey: BOTBQIXFHWFWHV-UHFFFAOYSA-N
• SMILES: CC1=CC=CC2=NC(=CN12)CNC(=O)C3=CC(=O)N4C=CC=CC4=N3

STM2120（Cat No.:I041134）is a small molecule inhibitor that targets the protein p38 MAPK (mitogen-activated protein kinase), a key regulator of inflammation, stress response, and cell signaling. By inhibiting p38 MAPK, STM2120 suppresses the activation of inflammatory cytokines and pathways associated with various diseases, including rheumatoid arthritis, cancer, and neurodegenerative disorders. This selective inhibition of p38 MAPK provides therapeutic potential for controlling inflammation and modulating disease progression. STM2120 is being investigated in preclinical studies for its efficacy in treating chronic inflammatory conditions and other diseases where p38 MAPK plays a critical role.